Small Intestinal Endocrine Cell Derived Exosomal ACE2 Protects Islet β-Cell Function by Inhibiting the Activation of NLRP3 Inflammasome and Reducing β-Cell Pyroptosis

DOI: https://doi.org/10.2147/ijn.s450337

IF: 7.033

2024-05-29

International Journal of Nanomedicine

Abstract:Songtao Yang, Jie Cao, Ying Wang, Qi Chen, Fangyu Li, Yuanyuan Gao, Rui Li, Li Yuan Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China Correspondence: Li Yuan, Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China, Email Background: The "gut-islets axis" is an important endocrine signaling axis that regulates islets function by modulating the gut microbiota and endocrine metabolism within the gut. However, the specific mechanisms and roles of the intestine in islets regulation remain unclear. Recent studies investigated that exosomes derived from gut microbiota can transport signals to remotely regulate islets β-cell function, suggesting the possibility of novel signaling pathways mediated by gut exosomes in the regulation of the "gut-islet axis.". Methods: The exosomes were isolated from the intestinal enteroendocrine cell-line STC-1cells culture supernatants treated with palmitate acid (PA) or BSA. Metabolic stress models were established by separately subjecting MIN6 cells to PA stimulation and feeding mice with a high-fat diet. Intervention with exosomes in vitro and in vivo to assess the biological effects of exosomes on islets β cells under metabolic stress. The Mas receptor antagonist A779 and ACE2ko mice were used to evaluate the role of exosomal ACE2. Results: We found ACE2, a molecule that plays a crucial role in the regulation of islets function, is abundantly expressed in exosomes derived from STC-1 under physiological normal condition (NCEO). These exosomes cannot only be taken up by β-cells in vitro but also selectively transported to the islets in vivo. Following intervention with NCEXO, both Min6 cells in a lipotoxic environment and mice on a high-fat diet exhibited significant improvements in islets β-cell function and β-cell mass. Further investigations demonstrated that these protective effects are attributed to exosomal ACE2, as ACE2 inhibits NLRP3 inflammasome activation and reduces β-cell pyroptosis. Conclusion: ACE2-enriched exosomes from the gut can selectively target islets, subsequently inhibiting NLRP3 inflammasome activation and β cell pyroptosis, thereby restoring islets β cell function under metabolic stress. This study provides novel insights into therapeutic strategies for the prevention and treatment of obesity and diabetes. Keywords: exosomes, ACE2, islets β cell, the NLRP3 inflammasome The incidence of metabolic syndrome and diabetes has been steadily increasing over the years, with a notable trend of affecting younger individuals. 1 As diabetes progresses and poor disease management, the rates of disability and mortality caused by diabetes and its complications are expected to rise significantly. Preserving the function of islets β cells has emerged as a pivotal topic in the field of prevention and treatment of metabolic syndrome and diabetes. The discovery of intestinal hormones such as GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic peptide) have laid the initial groundwork for establishing a cross-talk between the intestine and the islets. Building upon the "gut-islets axis" regulatory theory, the development and application of GLP-1 receptor agonists in the domain of diabetes treatment have ushered in a new paradigm for glycemic control in diabetes therapy. Consequently, the "gut-islets axis" regulatory theory has rapidly become a focal point of research attention. The "gut-islets axis" is an important endocrine signaling axis that involves the regulation and communication of islets function by the gut microbiota and intestinal endocrine metabolism. 2 Recent research has revealed that the intestine serves not only as the site for nutrient digestion and absorption but also as the largest endocrine organ in the body. It maintains the regulation of local intestinal microenvironment, distant tissues, and whole-body metabolism through an extensive endocrine system composed of enteroendocrine cells and intestinal microbiota. 3,4 Emerging studies have shown that, in addition to gut-derived endocrine hormones, intestinal cells can also exert regulatory control over distant tissues by secreting extracellular vesicles known as exosomes. These exosomes, ranging from 40 to 160 nm in size and containing functional proteins, mRNA, and miRNA, play specific biological effects under different pathological and physiological conditions. 5 Due to their diverse characteristics, these extracellular vesicles have become an indispensable component of intestinal endocrine regulation. The discovery of intestinal-originated exosomes con -Abstract Truncated-

pharmacology & pharmacy,nanoscience & nanotechnology